PMID: 9008303Dec 1, 1996Paper

Functional significance of polymorphism among MHC class II gene promoters

Tissue Antigens
J GuardiolaS Sartoris

Abstract

The functional significance of polymorphism among MHC class II promoters in man and mouse is here reviewed, mainly in terms of the hypothesis of differential expression. The hypothesis proposes that differences between antigen-presenting cells in MHC class II expression exert a co-dominant effect on the Th1-Th2 cytokine balance, such that class II molecules of one type come to control to a greater extent the production of one group of cytokines, and those of another type the production of the alternative group. The survey deals with the influence of signal strength and antigen-presenting cell type on T-cell subset differentiation; functional differences between MHC class II molecules not obviously related to determinant selection; disease protection mediated by HLA alleles; mechanisms possibly responsible for allotypic and isotypic bias; overdominance (heterozygous advantage) in selection for expression of class II alleles; MHC class II promoter structure and function; inter-locus and inter-allele variability within human MHC class II gene upstream regulatory regions; a comparison of these polymorphisms in mouse and man; read-out of class II promoter function; and a comparison with expression of MHC class I. We conclude that th...Continue Reading

References

Oct 1, 1978·The Journal of Experimental Medicine·P P JonesH O McDevitt
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D J Charron, H O McDevitt
Jan 1, 1992·Immunogenetics·G Del PozzoA Maffei
May 1, 1992·The Journal of Experimental Medicine·K InabaG Schuler
Jan 1, 1992·Annual Review of Immunology·L H Glimcher, C J Kara
Jan 1, 1991·The Journal of Experimental Medicine·L C AndersenB S Nepoom
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J P CogswellJ P Ting
Jan 1, 1990·Rheumatology International·B LangH H Peter
Apr 1, 1986·Journal of Immunogenetics·S K SinghC S David
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A L Hughes, M Nei
Oct 1, 1989·Immunological Reviews·T F GajewskiF W Fitch
Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·M D CooperC L Chen
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S P ChangW A Siddiqui
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F LatronR S Accolla
Jan 1, 1988·British Journal of Rheumatology·P StastnyX Gao
Aug 1, 1986·Annals of the Rheumatic Diseases·D JaraquemadaR N Maini
Feb 1, 1984·Clinical Immunology and Immunopathology·J S BritzR K Gershon
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L A MatisR H Schwartz
Jan 1, 1982·Immunogenetics·W P LafuseC S David
Jun 1, 1995·Immunology Today·E ZanelliC S David
Oct 1, 1995·The Journal of Experimental Medicine·M M EpsteinP Matzinger
Nov 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S A Abdulkadir, S J Ono
Nov 1, 1995·The Journal of Experimental Medicine·S ConstantK Bottomly

❮ Previous
Next ❯

Citations

Dec 4, 1998·Springer Seminars in Immunopathology·B MüllerZ Yin
Aug 1, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Paul E HarrisAntonella Maffei
May 19, 2005·Immunogenetics·Karin T Berggren, Jennifer M Seddon
Sep 15, 2006·Springer Seminars in Immunopathology·Sachiko HiroseToshikazu Shirai
Jun 15, 2005·Cellular Immunology·N A MitchisonH A Stephens
Nov 27, 1998·Human Immunology·P IndovinaM C Mazzilli
Nov 14, 1997·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·B Müller, A Mitchison
Dec 21, 2000·Clinical and Experimental Immunology·J V TaylorH C Polk
Oct 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Dagan A LoiselSusan C Alberts
Sep 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Danqing ZhangSachiko Hirose
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·M BaumgartB Müller
Nov 2, 2002·Molecular Biology and Evolution·Matthew V Rockman, Gregory A Wray
Nov 26, 2003·Journal of Evolutionary Biology·L Bernatchez, C Landry
Jan 3, 2009·Acta histochemica·Brigitte Müller-Hilke
Feb 8, 2007·International Journal of Immunogenetics·N A Mitchison, W Mayer
Jun 20, 2006·Biochimica Et Biophysica Acta·Paul E HarrisAntonella Maffei
Jan 2, 2009·Advances in Immunology·Laia MuixíDolores Jaraquemada
Aug 23, 2002·The American Journal of Gastroenterology·Albert J Czaja, Peter T Donaldson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.